Cargando…
HER-2 positivity is a high risk of recurrence of stage I gastric cancer
BACKGROUND/AIMS: The treatment of gastric cancer remains unsatisfactory. We aimed to investigate the prognostic value of immunohistochemical staining in gastric cancer. METHODS: We analyzed 505 (279 early staged, 226 advanced-staged) gastric cancer tissues from patients who underwent radical gastric...
Autores principales: | Kim, Seonhoo, Kim, Yeon-Ji, Chung, Woo Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588971/ https://www.ncbi.nlm.nih.gov/pubmed/34428882 http://dx.doi.org/10.3904/kjim.2020.243 |
Ejemplares similares
-
Prognostic effect of different etiologies in patients with gastric cardia cancer
por: Kim, Yeon-Ji, et al.
Publicado: (2019) -
Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients
por: Ha, June-Hyung, et al.
Publicado: (2014) -
Clinical outcomes of metachronous recurrence of gastric epithelial neoplasia based on Helicobacter pylori infection status and microsatellite stability
por: Kim, Yeon-Ji, et al.
Publicado: (2022) -
Analysis of Genomic Alterations Associated with Recurrence in Early Stage HER2-Positive Breast Cancer
por: Kim, Yong-Seok, et al.
Publicado: (2022) -
Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
por: Soo Park, Ji, et al.
Publicado: (2017)